JOURNAL OF PEDIATRIC INFECTION, cilt.18, sa.1, 2024 (ESCI, Scopus)
Objective: Invasive bacterial infections are among the most common causes of mortality and morbidity all over the world. With this study, it was aimed to evaluate pediatric invasive bacterial infections seen with the relaxation of COVID-19 pandemic measures. Material and Methods: Twenty-five children who were followed up in Eski & scedil;ehir Osmangazi University Faculty of Medicine Hospital between December 2022 and February 2023 with the diagnoses of pulmonary effusion/empyema, bacteremia, mastoiditis, and toxic shock syndrome were included in the study. The clinical, epidemiological and laboratory findings of the cases were evaluated. Results: Of the twenty-five children included in the study, 13 (52%) were boys and the median age of the study population was 70 (9-204) months. Pleural effusion/empyema was diagnosed in 16 (71%), mastoiditis in seven, bacteremia in eight, and toxic shock syndrome in two cases. Pathogenic microorganisms were identified in at least one culture and multiplex polymerase chain reaction (PCR) test in fifteen cases. While only medical treatment was given to eight cases, surgical and medical treatment was applied to 17 cases. Thirteen patients needed critical care. The average hospital stay was 12 (4-26) days, and one patient died during hospitalization. Conclusion: Invasive bacterial infections especially the incidence rates of cases with invasive Group A streptococcal infection (iGAS) have increased after the pandemic. Early recognition of cases and initiation of appropriate treatment in the early period are of critical importance. For this reason, both health professionals and the society should be informed about the disease and its early findings.